Haemonetics Corporation (HAE) EV/EBITDA US GAAP (year values) |
|||||||||
2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
EV/EBITDA | ? | 22.3 | 1.93 | 18.8 | 16.4 | 19.1 | |||
Changes by years, y/y, % | -49% | -91% | +873% | -100% | -7.5% |
Haemonetics Corporation. EV/EBITDA
Haemonetics Corporation. EV/EBITDA, changes, %
Haemonetics Corporation (HAE) EV/EBITDA US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
EV/EBITDA | ? | 14.4 | 20.0 | 19.4 | 19.0 | 18.1 | 19.1 | |
Changes by years, y/y, % | -27% | +14% | +12% | +4% | -1% | |||
Changes by quarters, q/q, % | -21% | +39% | -3% | -2% | -5% |